A pioneering team at the University of Cambridge has showcased today, June 25, work that is revolutionizing biological ...

Mathieu Bennet: In B-cell cloning, single-cell isolation occurs at two crucial stages. First, during the initial screening phase, high-throughput isolation is required to analyze a broad antibody ...

Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. On May 14, ...

Johnson & Johnson’s dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma: Milan Monday, June 16, 2025, 14:00 Hrs [IST] Johnson & Johnson an ...

This valuable manuscript investigates the localisation of nutrient receptors in bloodstream stage trypanosomes, with implications for both nutrient uptake and immune evasion. Results after direct ...

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin's lymphoma and is curable in more than 60% of patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and ...

Q My mother has been diagnosed with breast cancer, and I’m helping with her medical appointments. Her oncologist says she ...

Could consciousness emerge from quantum processes in tiny tubes inside brain cells? Research suggests these microscopic ...

PRDX6 and GSTP1 identified as promising enzyme targets for neuroblastoma, offering an alternative to retinoic acid differentiation therapy.

It follows a previous report showing that the Werner syndrome protein WRN and its interacting protein WRNIP1 are indispensable for translesion DNA synthesis (TLS) by Y-family DNA polymerases (Pols).

For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...